Precigen Inc (NASDAQ: PGEN) on Thursday, soared 1.46% from the previous trading day, before settling in for the closing price of $1.37. Within the past 52 weeks, PGEN’s price has moved between $0.65 and $2.17.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -19.53% over the past five years. The company achieved an average annual earnings per share of 42.55%. With a float of $162.39 million, this company’s outstanding shares have now reached $292.87 million.
Let’s look at the performance matrix of the company that is accounted for 143 employees. In terms of profitability, gross margin is -29.11%, operating margin of -3440.31%, and the pretax margin is -3261.86%.
Precigen Inc (PGEN) Insider and Institutional Ownership
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Precigen Inc is 44.77%, while institutional ownership is 25.71%. The most recent insider transaction that took place on Aug 09 ’24, was worth 50,000. In this transaction SVP, IP Affairs of this company bought 58,823 shares at a rate of $0.85, taking the stock ownership to the 743,097 shares. Before that another transaction happened on Aug 09 ’24, when Company’s Director bought 23,529,411 for $0.85, making the entire transaction worth $19,999,999. This insider now owns 64,547,214 shares in total.
Precigen Inc (PGEN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 42.55% per share during the next fiscal year.
Precigen Inc (NASDAQ: PGEN) Trading Performance Indicators
Precigen Inc (PGEN) is currently performing well based on its current performance indicators. A quick ratio of 4.76 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 104.27.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.48, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach 0.02 in one year’s time.
Technical Analysis of Precigen Inc (PGEN)
Precigen Inc (NASDAQ: PGEN) saw its 5-day average volume 1.12 million, a negative change from its year-to-date volume of 1.85 million. As of the previous 9 days, the stock’s Stochastic %D was 76.32%. Additionally, its Average True Range was 0.15.
During the past 100 days, Precigen Inc’s (PGEN) raw stochastic average was set at 48.64%, which indicates a significant decrease from 63.64% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 127.51% in the past 14 days, which was higher than the 101.52% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6729, while its 200-day Moving Average is $1.2294. Nevertheless, the first resistance level for the watch stands at $1.4367 in the near term. At $1.4833, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5367. If the price goes on to break the first support level at $1.3367, it is likely to go to the next support level at $1.2833. The third support level lies at $1.2367 if the price breaches the second support level.
Precigen Inc (NASDAQ: PGEN) Key Stats
Market capitalization of the company is 408.72 million based on 294,043K outstanding shares. Right now, sales total 3,930 K and income totals -126,240 K. The company made 1,190 K in profit during its latest quarter, and -19,730 K in sales during its previous quarter.
